Home » FDA Approves NovoLog for Use in Children and Adolescents
FDA Approves NovoLog for Use in Children and Adolescents
Novo Nordisk announced that the U.S. Food and Drug Administration has approved NovoLog (insulin aspart [rDNA origin] injection) for continuous subcutaneous insulin infusion (CSII) by external insulin pump in pediatric patients between the ages of 4 and 18 years.
CNN Money
CNN Money
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May